Recovered COVID-19 patients may need only a single vaccine dose, suggests study
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […]
» Read moreHome »
The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […] Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted […] A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can […]
Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay
Scientists discover new immunotherapy target for malignant brain tumors
Promising path found for COVID-19 therapeutics
